Low-Cost Synthesis of Tuberculosis Drugs Using Synthetic Biology

An estimated 9 million people are infected with multi drug-resistant TB; 1.4 million die per year. Successful completion of this University of Toronto-led project will lead to an innovative yeast-based bioprocess for the low-cost synthesis of antibiotic and lower the cost (now $5,000 per patient) of treating the disease in the developing world. "